These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33435110)

  • 1. Peptide Amphiphile Micelle Vaccine Size and Charge Influence the Host Antibody Response.
    Zhang R; Smith JD; Allen BN; Kramer JS; Schauflinger M; Ulery BD
    ACS Biomater Sci Eng; 2018 Jul; 4(7):2463-2472. PubMed ID: 33435110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.
    Zhang R; Kramer JS; Smith JD; Allen BN; Leeper CN; Li X; Morton LD; Gallazzi F; Ulery BD
    AAPS J; 2018 Jun; 20(4):73. PubMed ID: 29858738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Delivery Method and Nanoparticle Charge Influence Peptide Amphiphile Micelle Vaccine Bioactivity.
    Zhang R; Rygelski BT; Kruse LE; Smith JD; Wang X; Allen BN; Kramer JS; Seim GF; Faulkner TJ; Kuang H; Kokkoli E; Schrum AG; Ulery BD
    bioRxiv; 2024 Oct; ():. PubMed ID: 38915689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide Amphiphile Micelles for Vaccine Delivery.
    Barrett JC; Tirrell MV
    Methods Mol Biol; 2018; 1798():277-292. PubMed ID: 29868967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modular Peptide Amphiphile Micelles Improving an Antibody-Mediated Immune Response to Group A Streptococcus.
    Barrett JC; Ulery BD; Trent A; Liang S; David NA; Tirrell MV
    ACS Biomater Sci Eng; 2017; 3(2):144-152. PubMed ID: 29242824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
    Moyle PM
    Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide amphiphile micelles self-adjuvant group A streptococcal vaccination.
    Trent A; Ulery BD; Black MJ; Barrett JC; Liang S; Kostenko Y; David NA; Tirrell MV
    AAPS J; 2015 Mar; 17(2):380-8. PubMed ID: 25527256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
    Zuckermann FA; Martin S; Husmann RJ; Brandt J
    Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving vaccine performance with adjuvants.
    Vogel FR
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S266-70. PubMed ID: 10875797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cationic Micelle Complex Improves CD8+ T Cell Responses in Vaccination Against Unmodified Protein Antigen.
    Brubaker CE; Panagiotou V; Demurtas D; Bonner DK; Swartz MA; Hubbell JA
    ACS Biomater Sci Eng; 2016 Feb; 2(2):231-240. PubMed ID: 33418636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
    de Veer M; Meeusen E
    Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic polypeptide micelle-based antigen delivery system: a simple and robust adjuvant to improve vaccine efficacy.
    Luo Z; Li P; Deng J; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
    J Control Release; 2013 Sep; 170(2):259-67. PubMed ID: 23742880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adjuvants in retroviral vaccines.
    Vogel FR
    Int J Immunopharmacol; 1995 Feb; 17(2):85-90. PubMed ID: 7657411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic micelle based vaccine induced potent humoral immune response through enhancing antigen uptake and formation of germinal center.
    Luo Z; Shi S; Jin L; Xu L; Yu J; Chen H; Li X
    Colloids Surf B Biointerfaces; 2015 Nov; 135():556-564. PubMed ID: 26311662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future perspectives for vaccine development.
    Stevens VC
    Scand J Immunol Suppl; 1992; 11():137-43. PubMed ID: 1514029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linker chemistry determines secondary structure of p5314-29 in peptide amphiphile micelles.
    Missirlis D; Farine M; Kastantin M; Ananthanarayanan B; Neumann T; Tirrell M
    Bioconjug Chem; 2010 Mar; 21(3):465-75. PubMed ID: 20166676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Modular Antigen Presenting Peptide/Oligonucleotide Nanostructure Platform for Inducing Potent Immune Response.
    Tohumeken S; Gunduz N; Demircan MB; Gunay G; Topal AE; Khalily MA; Tekinay T; Dana A; Guler MO; Tekinay AB
    Adv Biosyst; 2017 May; 1(5):e1700015. PubMed ID: 32646154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH
    Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.